Although caspase-8 has an established role as an initiator of death receptor-mediated apoptosis, the function of its closest homolog, caspase-10, is almost completely unknown. To gain a closer insight into the physiological function of caspase-10, we compared the cleavage of known caspase-8 substrates by both initiator caspases. We demonstrate that caspase-10 and -8 have overlapping cleavage preferences for several substrates such as the kinases RIP and PAK2. Interestingly, in other substrates, such as the Bcl-2 protein Bid, we found additional and distinct cleavage sites for both caspases, which might have important consequences for mitochondrial targeting and propagation of the death signal. Caspase-8 and -10 also caused different interchain cleavage patterns of their enzyme precursors. Together, these results suggest that caspase-8 and -10, despite having overlapping functions, also have selective substrate cleavage specificities and might thereby exert nonredundant roles in apoptosis signaling. Oncogene (2006) 25, 152-159.
Although caspase-8 has an established role as an initiator of death receptor-mediated apoptosis, the function of its closest homolog, caspase-10, is almost completely unknown. To gain a closer insight into the physiological function of caspase-10, we compared the cleavage of known caspase-8 substrates by both initiator caspases. We demonstrate that caspase-10 and -8 have overlapping cleavage preferences for several substrates such as the kinases RIP and PAK2. Interestingly, in other substrates, such as the Bcl-2 protein Bid, we found additional and distinct cleavage sites for both caspases, which might have important consequences for mitochondrial targeting and propagation of the death signal. Caspase-8 and -10 also caused different interchain cleavage patterns of their enzyme precursors. Together, these results suggest that caspase-8 and -10, despite having overlapping functions, also have selective substrate cleavage specificities and might thereby exert nonredundant roles in apoptosis signaling.
Oncogene ( Keywords: apoptosis; caspase-10; caspase-8; Bid; RIP Caspases, a family of aspartate-specific cysteine proteases, play an essential role in signal transduction and effector processes of apoptosis (Los et al., 1999; Schwerk and Schulze-Osthoff, 2003) . Based on their structure and order in cell death pathways, caspases can be divided into initiator and effector caspases. Effector caspases are normally present as inactive precursors and are proteolytically activated by upstream initiator caspases. Effector caspases, such as caspase-3, -6 and -7, generally contain only a small prodomain and cleave diverse cellular substrates (Fischer et al., 2003) . The initiator caspases such as caspase-8, -9 and -10, in contrast, contain a long prodomain that is used to recruit the enzymes to high-molecular weight activation platforms, including the apoptosome in the mitochondrial pathway or the death-inducing signaling complex (DISC) in the death receptor pathway.
Caspase-8 is a key mediator of apoptotic signals sensed by the death receptors CD95, TNF-R1 and TRAIL-R1/TRAIL-R2 and activated upon receptor binding of the respective death ligands (Schulze-Osthoff et al., 1998) . Initially, receptor-driven oligomerization of caspase-8 was thought to activate the enzyme through facilitating autoproteolysis of procaspase-8 molecules (Salvesen and Dixit, 1999) . Recent studies, however, have proposed that dimerization rather than interchain proteolysis is the critical event for caspase-8 activation, and subsequent autoprocessing of the enzyme has been suggested to merely stabilize caspase-8 dimers (Boatright et al., 2003; Donepudi et al., 2003) .
In the case of TRAIL-receptor 1/2 and CD95, caspase-8 is directly recruited into the DISC by the adapter protein FADD. Signaling through TNF-R1, in contrast, appears to be more complex and to proceed via two sequential signaling complexes (Harper et al., 2003; Micheau and Tschopp, 2003) . It was suggested that following TNF stimulation, a first complex is formed at the cell membrane, which contains TNF-R1, the adapter protein TRADD and the NF-kB-activating signaling components RIP and TRAF2. Upon dissociation of TNF-R1, a second different complex is formed in the cytosol, which recruits the apoptotic machinery, such as FADD and caspase-8. This model might explain how TNF-R1 can mediate both survival as well as death signals. During TNF-R1 signaling, RIP activates NFkB-controlled survival pathways involving the transcriptional activation of antiapoptotic proteins such as c-FLIP or inhibitors of apoptosis proteins (IAPs). If caspase-8 is simultaneously activated, it can disrupt NF-kB activation by the direct cleavage of RIP, thereby intervening with survival signals and starting the cell death program. Another important function of caspase-8 is the cleavage of the Bcl-2 family member Bid, which interconnects the death receptor and the mitochondrial pathway (Li et al., 1998; Luo et al., 1998) . Upon cleavage by caspase-8, the truncated Bid translocates to the mitochondria, where it interacts with the proapoptotic Bcl-2 family members Bax and Bak to mediate the release of cytochrome c and the activation of caspase-9.
While the function of caspase-8 in death receptormediated apoptosis is well established, the physiological role of caspase-10, which is closely related to caspase-8 and has so far only been found in humans, remains obscure. Caspase-8 and -10 are both death effector domain-containing caspases and share together with c-FLIP the same gene locus on chromosome 2q33-34 Vincenz and Dixit, 1997) . The possibility that caspase-10 evolved in humans as a mere redundant duplicate of caspase-8 is intriguing. Accordingly, both enzymes were recently found to be recruited to death receptors, although it is still highly controversial whether caspase-10 can functionally substitute for caspase-8 (Vincenz and Dixit, 1997; Kischkel et al., 2001; Wang et al., 2001b; Sprick et al., 2002; Milhas et al., 2005) . Nevertheless, caspase-10 mutations have been recently associated with a rare immunological disorder, called autoimmune lymphoproliferative syndrome (ALPS), a disease that was originally believed to be restricted to mutations in the CD95 receptor-ligand system (Wang et al., 1999) . These caspase-10-inactivating mutations were proposed to be causative for the disease (ALPS type II), as mature dendritic cells and activated peripheral T cells from these patients were resistant towards death ligand-induced cell death. Humans with mutant caspase-8, while also exhibiting defects in lymphocyte apoptosis, have in addition pronounced defects in their ability to activate lymphocytes, with resulting immunodeficiency (Chun et al., 2002) . With regard to the lethal phenotype of caspase-8 deficiency in mouse knockout models (Varfolomeev et al., 1998) , this argues for a partial compensation of caspase-8 by caspase-10 in humans, but also suggests additional, nonoverlapping functions. Another interesting finding is the high frequency of loss of caspase-10 expression or caspase-10 mutations in human tumors, especially in breast carcinomas (Kischkel et al., 2001) . Therefore, although caspase-8 and -10 might be redundant in some aspects, specific roles and nonoverlapping functions of both caspases are highly conceivable (Engels et al., 2005) .
An important key for the understanding of caspase function is the identification of relevant caspase substrates. For caspase-8, a limited number of substrates, often with crucial roles for the cell death process, have been found (Fischer et al., 2003) , whereas substrates of caspase-10 are completely unknown. To access the physiological function of caspase-10, we compared in the present study the cleavage of various substrates and found overlapping as well as distinct substrate specificities of caspase-8 and -10.
For the substrate assays, caspase-10 as well as caspase-3 and -8 were expressed in Escherichia coli and purified to near homogeneity ( Figure 1a ). To enforce caspase dimerization, we included sodium citrate in the reaction buffer. As previously reported (Boatright et al., 2003) , the activities of caspase-8 and -10 could be greatly enhanced by the kosmotropic salt (Figure 1b and c) . In contrast to the initiator caspases, for which dimerization rather than interchain proteolysis is important, cleavage into the p10 and p20 subunits is strictly required for the activation of effector caspases. In line, caspase-3 showed only a mild increase in reactivity under the same conditions ( Figure 1c ). The presence of citrate was shown to have no influence on the substrate specificity of caspase-8 and -9 against a positional scanning library (Boatright et al., 2003) , and in our study also substrate cleavage by caspase-8 and -3 was not altered. Having shown the proteolytic activity of the caspases, we subsequently in vitro translated various substrates in the presence of radioactive methionine and cysteine and incubated them with various concentrations of the recombinant caspases. Following different incubation times, substrate cleavage was analysed by electrophoresis and autoradiography.
An important substrate of caspase-8 is RIP, the cleavage of which impairs NF-kB survival signaling (Lin et al., 1999; Martinon et al., 2000) . RIP is cleaved by caspase-8 during TNF-R1 and CD95-mediated apoptosis at LQLD (324), separating the N-terminal kinase from the C-terminal death domain (Figure 2a ). Wang et al. (2001b) could not detect RIP cleavage upon CD95 ligand treatment of caspase-8-deficient Jurkat T cells transiently transfected with caspase-10, while caspase-8-reconstituted cells readily cleaved RIP under these conditions. In contrast, we observed the same pattern of RIP cleavage, regardless of whether caspase-10 or -8 were applied (Figure 2b ). Comparison of various caspase concentrations revealed that RIP was even more efficiently cleaved by caspase-10 than by caspase-8 or -3, suggesting that caspase-10 through the cleavage of RIP will also inhibit NF-kB survival signaling. It should be noted that the enzyme units used were based on the cleavage of the peptide substrate IETD, which has distinct binding affinities to the individual caspases. Therefore, differences in the molar amounts of the caspases might have also contributed to the distinct kinetics of substrate cleavage.
Other kinases are also important caspase targets, and many kinases are involved as upstream mediators in the initiation and regulation of cellular-death pathways (Fischer et al., 2003) . The p21-activated kinase 2 (PAK2) belongs to a family of Ser/Thr protein kinases that are normally activated by Rho family GTPases through G-protein-coupled receptors (Knaus et al., 1995) . Activation of full-length PAK2 stimulates cell survival, which is mediated in part by phosphorylation and subsequent inhibition of the proapoptotic Bcl-2 protein Bad (Jacobi et al., 2001) . In contrast, at the onset of apoptosis induced by death receptors or growth factor withdrawal, cleavage of PAK2 at SHVD (212) separates its N-terminal regulatory from the C-terminal catalytic domain, resulting in a proapoptotic, constitutively active kinase (Figure 2a) . Cleavage of PAK2 has been associated with some of the morphological features of apoptosis such as cell rounding and apoptotic body formation (Lee et al., 1997; Rudel and Bokoch, 1997) . In our study, PAK2 was readily cleaved by caspase-10, -8 and -3 (Figure 2b ). Remarkably, PAK2 seemed to be an even better substrate for caspase-10 than for caspase-8 or -3. PAK2 cleavage was complete after 3 h with only 30 U of caspase-10, whereas even 100 U of caspase-8 or -3 did not result in complete cleavage. During death receptor-mediated apoptosis, caspase-10 could therefore be not only redundant, but even the primary caspase responsible for PAK2 cleavage.
The Ca 2 þ /calmodulin-dependent protein kinase-like kinase (CaMKLK), which has been implicated in neuronal apoptosis, is another caspase-8 substrate included in this investigation (Figure 2a ). The cleavage of CaMKLK at DEND (62) has been reported to generate a 43 kDa C-terminal fragment and a small N-terminal fragment with proapoptotic activity (Kruidering et al., 2001) . CaMKLK was readily cleaved at DEND (62) by caspase-10 as well as by caspase-8 and -3. Interestingly, caspase-10, unlike caspase-8 and -3, also processed a CaMKLK form mutated in the classical caspase cleavage site (D62N). The resultant protein fragment was of similar size to the one generated by DEND (62) processing, arguing for either a nearby alternative or an additional unknown C-terminal site.
The differential cleavage of the CaMKLK mutant suggests that caspase-8 and -10 have distinct substrate specificities. Similarly, we found that a noncleavable mutant of another substrate, the B-cell receptorassociated protein 31 (BAP31), an integral membrane protein of the endoplasmic reticulum, was still cleaved Figure 1 Expression and proteolytic activity of the recombinant caspases. (a) Purification of caspase-10, -8 and -3. Caspase-8 and -3 were expressed and purified as described previously (Lauber et al., 2001) . Full-length caspase-10 cDNA was generated from Jurkat cell mRNA by RT-PCR and cloned into the BamHI/XhoI restriction sites of the vector pcDNA4 (Invitrogen). Caspase-10a cDNA lacking the prodomain sequence was then cloned into the pET28a þ vector (Novagen) using BamHI and XhoI restriction sites. After transformation of E. coli Bl21 cells, purification of caspase-10a was carried out as described (Koeplinger et al., 2000) . The active p10 and p20 subunits of the individual caspases and the p29 intermediate fragment of caspase-10 are indicated. (b) Caspase-10 activity is enhanced in the presence of the kosmotropic salt sodium citrate. Caspase activity was measured in a fluorimetric assay using the synthetic substrate ac-IETD-amc (ICN). Indicated units of caspase-10 were added to 50 mM ac-IETD-amc in the presence or absence of 1 M sodium citrate. Caspase activity (1 U) was defined as the amount of enzyme which cleaves 1 nmol IETD substrate in the presence of 1 M citrate in 1 h at 371C. Substrate cleavage was monitored for up to 160 min. (c) Effect of the kosmotropic citrate on caspase-3, -8 and -10 activity. Citrate greatly enhances the activity of the initiator caspase-8 and -10, whereas the effect on caspase-3 is less pronounced. Recombinant caspase-10, -8 and -3 (30 U) were incubated for 160 min with 50 mM ac-IETD-amc in the presence or absence of 1 M sodium citrate.
Substrate cleavage by caspase-8 and -10 U Fischer et al Cleavage by caspase-8 at LQLD (324) separates the kinase and death domain and renders RIP unable to activate NF-kB (Lin et al., 1999) . PAK2 (second panel) consists of an N-terminal proline-rich SH3 binding domain (PXXP) and a p21 GTPase-binding domain (PBD). Cleavage of PAK2 at SHVD (212) separates the N-terminal regulatory from the C-terminal catalytic domain (Rudel and Bokoch, 1997; Lee et al., 1997) , resulting in a constitutively active form of the kinase. Caspase cleavage, in addition, inactivates a nuclear export signal (NES, aa 197-246) resulting in nuclear accumulation of the fragment containing the catalytic domain and nuclear localization motif (NLS, aa 245-251) (Jacobi et al., 2003) . Cleavage of CaMKLK (third panel) by caspases at DEND (62) leads to formation of an N-terminal proapoptotic p10 fragment and a C-terminal fragment with reduced kinase activity (Kruidering et al., 2001) . BAP-31 (lower panel), an ER-resident protein with three transmembrane (TM) domains, is cleaved by caspase-8 at two identical cleavage sites (AAVD-164, AAVD-238) giving rise to a proapoptotic p20 fragment (Ng et al., 1997) . The molecular weights of the proteolytic fragments are indicated below. (b) Cleavage of the substrates RIP (upper panel), PAK2 (second panel), CaMKLK (third panel) and BAP31 (lower panel). Plasmids encoding the caspase-8 substrates murine RIP (Grimm et al., 1996) , human PAK2 (Rudel and Bokoch, 1997) , rat CaMKLK and human BAP31 as well as caspase cleavage sitedirected mutants of CaMKLK (D62N) (Kruidering et al., 2001 ) and BAP31 (Nguyen et al., 2000) were in vitro translated in the presence of 35 S-labeled methionine and cysteine using the TNT assay (Invitrogen). An aliquot of the reaction was then incubated for 3 h in the presence of 1 M sodium citrate with or without 10, 30 or 100 U of caspase-10, -8 and -3. The reactions were terminated in SDS sample buffer, resolved by 12-15% PAGE and detected by autoradiography. The full-length forms of the proteins are indicated by an open arrowhead, and the proteolytic fragments by a closed arrowhead.
Substrate cleavage by caspase-8 and -10 U Fischer et al by caspase-10, but not by caspase-8 (Figure 2b ). In the mutant, both aspartic acid residues of the known cleavage sites at AAVD (164) and AAVD (238) had been altered into alanine (Nguyen et al., 2000) . In contrast, wild-type BAP31 was cleaved by caspase-10, -8 and -3. BAP31 was shown to recruit caspase-8 to the ER and is then cleaved itself by caspase-8. Overexpression of the p20 cleavage product of BAP31 is proapoptotic and causes disturbed protein transport from the ER to the Golgi apparatus (Ng et al., 1997) .
Another most interesting difference between caspase-8 and -10 was seen in the cleavage of the BH3-only protein Bid (Figure 3 ). Caspase-10 recognized the LQTD (60) site, as did caspase-8 and -3, resulting in the generation of the typical proapoptotic p15 tBid fragment (Figure 3b ). In addition, caspase-10 reproducibly caused a very fast and further cleavage of Bid at a second site at IEAD (75). This cleavage site has previously been postulated to be specific for granzyme B, resulting in the generation of a p13 Bid fragment (Li et al., 1998; Barry et al., 2000) . Moreover, caspase-10, but none of the other caspases, was able to process a cleavage site-mutated (D60A) Bid form into the p13 Bid fragment (Figure 3b ). This differential truncation of Bid by caspase-10 and -8, which was also visible after prolonged incubation for up to 24 h with various enzyme concentrations, is very likely to have important consequences for downstream mitochondrial signaling. Upon cleavage by caspase-8, the proapoptotic p15 fragment of Bid undergoes N-myristoylation at a glycine residue that becomes newly exposed by the cleavage (Zha et al., 2000) . This postproteolytic N-myristoylation then enables Bid to efficiently target mitochondria and serves as an activating switch, which strongly enhances cytochrome c release. In contrast, cleavage of Bid by caspase-10 does not create such a myristoylation signal, which might result in a reduced targeting of tBid to mitochondria. Moreover, the use of different cleavage sites by caspase-10 and -8 might also result in a different accessibility of Bid for caspase cleavage. It has been demonstrated that in healthy cells, Bid is protected from caspase-8 cleavage through its phosphorylation by casein kinases I and II (Desagher et al., 2001; DegliEsposti et al., 2003) . Casein kinase phosphorylates Bid within or in close proximity to the first and caspase-8-specific recognition site at Thr (59), Ser (65) and Ser (64). However, since the caspase-10 cleavage site at IEAD (75) is further downstream, BID cleavage should not be inhibited by phosphorylation. Therefore, the truncation of Bid by caspase-10 might be under less stringent post-translational control and allow efficient Bid cleavage also in its phosphorylated state. Finally, the generation of distinct Bid fragments might also affect their interaction with the Bcl-2 multidomain proteins Bak and Bax. In this context, it was reported that the granzyme B and caspase-8 cleavage products of Bid can specifically interact with either Bak or Bax to mediate cytochrome c release (Wang et al., 2001a; Cartron et al., 2003) . Although these findings are controversial and require further investigation, this would suggest that caspase-8 or -10 could selectively trigger mitochondrial activation in tumor cells mutated in either Bax or Bak.
We also analysed the processing of the in vitro translated caspases by the purified recombinant enzymes. Recombinant caspase-8 did not cause efficient processing of its own precursor and only partially cleaved procaspase-8 to the p43 intermediate fragment (Figure 4b , upper panel). This observation is consistent with recent data showing that the substrate specificity of processed caspase-8 is remarkably different from the specificity of the uncleaved caspase-8 dimer (Boatright et al., 2003; Chang et al., 2003) . Thus, only the uncleaved and DISCbound caspase-8 dimer appears to have a high affinity to other procaspase-8 molecules, resulting in efficient crossactivation. Whereas the fully processed enzyme Figure 3 Bid is differentially cleaved by caspase-8 and caspase-10. (a) Schematic diagram of the BH3-only protein Bid. Bid contains a BH3 domain and a preceding loop region that is highly susceptible to cleavage by several proteases including caspase-3, -8 and -10 as well as granzyme B (Li et al., 1998; Barry et al., 2000) and lysosomal proteases (Stoka et al., 2001) . Cleavage by caspase-3 and -8 at LQTD (60) exposes a hidden myristoylation signal that is thought to be involved in mitochondrial targeting of the truncated p15 form of Bid (Zha et al., 2000) . Potential phosphorylation sites are marked by asterisks. Phosphorylation might negatively regulate susceptibility of Bid to caspase cleavage (Desagher et al., 2001; Degli-Esposti et al., 2003) . (b) Plasmids encoding wild-type human Bid as well as a Bid with mutated caspase cleavage site (D60A) were subjected to in vitro translation and caspase cleavage as described in Figure 2b . Whereas caspase-8 and -3 generate a p15 Bid fragment, cleavage of Bid by caspase-10 results in a p13 fragment. Mutation of Asp (60) to Ala inhibits cleavage of Bid by caspase-8 and -3, but not the generation of p13 by caspase-10.
Substrate cleavage by caspase-8 and -10 U Fischer et al has only limited affinity for its own zymogen, this restriction did obviously not apply to caspase-10, which efficiently processed procaspase-8 at REQD (216), releasing the p26 prodomain and an intermediate p28 fragment consisting of the large and small subunits. Furthermore, a consecutive weak processing to the p18 mature subunit was visible (Figure 4b, upper panel) . In contrast to procaspase-8, procaspase-10 was processed by both active caspase-8 and -10 to the p43 cleavage product containing the prodomain and large subunit (Figure 4b, middle panel) . In addition, a slight but clearly visible further cleavage of this intermediate fragment to the mature p18 caspase-8 subunit occurred through both caspases. Thus, although dimerization of the initiator caspases is presumably the principal activation mechanism, it may not be an absolute prerequisite, and the direct proteolytic processing of initiator caspases by caspase-10 is possible. Caspase-8 activation in the absence of death receptor-mediated dimerization has been recently reported to occur also Figure 4 Caspase-10 can process caspase-8 to p18, whereas caspase-8 itself cannot. (a) Schematic diagram of caspase-8, -10 and -3. The initiator caspase-10 and -8 harbor large prodomains containing two closely related death effector domains (DED) for interaction with other DED-containing proteins such as FADD. In contrast, effector caspase-3 possesses only a short prodomain of 2 kDa. Processing at the indicated cleavage sites (arrows) results in formation of an active heterotetrameric caspase-complex of two small Ep10 and two large Ep20 domains. Unlike caspase-3, the initiator caspases also harbor intrinsic enzymatic activity if dimerized as full-length zymogens (Boatright et al., 2003; Chang et al., 2003) . (b) Plasmids encoding human caspase-8a, -10a and -3 were cloned into pcDNA4 or pcDNA3, in vitro translated and subjected to caspase cleavage as described in Figure 2b . Upper panel: Caspase-8a was cleaved by caspase-10, and to a lesser extent by caspase-3, predominantly at REQD (216) releasing the p26 prodomain and an intermediate p28 fragment. Further cleavage to the p18 active subunit was less efficient. Active caspase-8 processed in vitro translated caspase-8 only to the p43 fragment, even after prolonged incubation times (up to 10 h, data not shown). Middle panel: Caspase-10a (as well as caspase-10b and -10d, data not shown) was processed by caspase-10a and -8a to the intermediate p43 fragment and the p17 active subunit. Processing by caspase-3 was far less efficient. Lower panel: Cleavage of caspase-3 occurred by all investigated caspases, however, with different cleavage site preference. Caspase-8 cleaved caspase-3 at IETD (175), resulting in a p11 and a p20 fragment that was further autoproteolytically cleaved at ESMD (28) to the p17 subunit. Caspase-3 cleavage by caspase-10 at IETD (175) was less pronounced compared to caspase-8 and conversion of the p20 to the p17 fragment was only seen after prolonged incubation (data not shown). Caspase-3 cleaved its in vitro-translated precursor preferentially at ESMD (28) resulting in the p30 intermediate fragment lacking the prodomain. Further cleavage to the p17 and p12 subunits was less efficient.
Substrate cleavage by caspase-8 and -10 U Fischer et al during chemotherapeutic drug-induced apoptosis or by direct proteolysis through granzyme B (Sohn et al., 2005; Murphy et al., 2005) .
Finally, although cleavage of procaspase-3 occurred through all investigated caspases, it was with different cleavage site preference (Figure 4b, lower panel) . Caspase-8 cleaved procaspase-3 at IETD (175), resulting in a p11 and a p20 fragment that was further autoproteolytically cleaved at ESMD (28) to the p17 active subunit. Caspase-3 cleavage by caspase-10 at IETD (175) was less pronounced compared to caspase-8 and conversion of the p20 to the p17 fragment was only seen after prolonged incubation (data not shown). In contrast, autoprocessing of caspase-3 almost did not occur. Caspase-3 cleaved its own precursor at ESMD (28), resulting in the p30 intermediate fragment lacking the prodomain, while further cleavage to the p17 and p12 subunits was less efficient.
In summary, we demonstrate that caspase-10 efficiently cleaves caspase-8 substrates at overlapping, but in several cases also at distinct cleavage sites. In particular, the generation of p15-tBid by caspase-8 on the one hand, and p13-tBid by granzyme B and caspase-10 on the other, could be of biological importance and favors a currently discussed model of differential interaction of distinct tBid species with the downstream signaling actors Bax or Bak. In addition, the observed differences concerning self-processing and processing of the related procaspases hint at distinct regulatory mechanisms imposed on the two related caspases.
Caspase-8 seems to be the more tightly regulated caspase of the two, which would correspond to the finding that caspase-8 is more susceptible to inhibition, for instance by CrmA, compared to caspase-10 ( Srinivasula et al., 1996; Garcia-Calvo et al., 1998) . One might speculate that caspase-10 has evolved to exert a function similar to granzyme B as a broad and fast initiator of apoptosis. This assumption might explain the frequent downregulation of caspase-10 protein in human tumors and transformed cell lines (Kischkel et al., 2001; Wang et al., 2001b) . The function of caspase-8, in contrast, might be more diverse and not restricted only to apoptotic pathways. In this context, caspase-8 À/À mice exhibit not only impaired death receptor-mediated apoptosis but also poorly developed heart musculature and a deficiency in myeloid progenitor cells (Varfolomeev et al., 1998) . In addition, patients suffering from autoimmune disease due to caspase-8 mutation harbor not solely apoptosis defects but also deficient T-cell activation (Chun et al., 2002) . Together, our results add important new information on caspase-10 function and provide a useful tool for future research.
